Questionnaires, spirometry and PEF monitoring in epidemiological studies on elderly respiratory patients

European Respiratory Journal, Supplement

Volumn 21, Issue 40, 2003, Pages

  Bellia, V ^a   Pistelli, F ^b   Giannini, D ^b   Scichilone, N ^a   Catalano, F ^a   Spatafora, M ^a   Hopps, R ^a   Carrozzi, L ^b   Baldacci, S ^c   Di Pede, F ^b   Paggiaro, P ^b   Viegi, G ^c  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Elderly; Peak expiratory flow; Questionnaires; Reference values; Spirometry

Indexed keywords

ACCURACY; AGED; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CONFERENCE PAPER; FORCED EXPIRATORY VOLUME; HUMAN; LUNG VOLUME; MONITORING; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; REFERENCE VALUE; RELIABILITY; RESPIRATORY TRACT DISEASE; RISK FACTOR; SPIROMETRY; VALIDATION PROCESS; ADULT; AIR POLLUTION; EPIDEMIOLOGY; FEMALE; MALE; REVIEW;

ADULT; AGED; AIR POLLUTION; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; MALE; PEAK EXPIRATORY FLOW RATE; QUESTIONNAIRES; REFERENCE VALUES; RESPIRATORY TRACT DISEASES; RISK FACTORS; SPIROMETRY;

EID: 17944389978     PISSN: 09041850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (67)

1. Samet JM. A historical and epidemiologic perspective on respiratory symptoms questionnaires. Am J Epidemiol 1978; 108: 435-446.
2. Commission of the European Communities. Directorate-General XII for science, research and development. Cost 613/ 2 Report Series on Air Pollution Epidemiology. Brunekeef B, ed. Report No. 2. Health Effect Assessment. Brussels, Commission of the European Communities, 1992, pp. 45-53.
3. Armstrong BK, White E, Saracci R. Methods of exposure measurement. In: Kelsey JL, Marmot MG, Stolley PD, Vessey Martin PV, eds. Principles of Exposure Measurement in Epidemiology. Monographs in Epidemiology and Biostatistics. Vol. 21. Oxford, Oxford University Press, 1992; pp. 22-48.
4. Liard R, Neukirch F. Questionnaires: a major instrument for respiratory epidemiology. Eur Respir Mon 2000; 15: 154-166.
5. Medical Research Council, Committee on the Aetiology of Chronic Bronchitis. Standardized questionnaire on respiratory symptoms. Br Med J 1960; 2: 1665.
6. Holman WJ, Dawlish, Devon, eds. Medical Research Council's Committee on Research into Chronic Bronchitis. A) Questionnaire on respiratory symptoms; B) Instructions for the use of the questionnaires on respiratory symptoms. London, Medical Research Council, 1966.
7. Medical Research Council's Committee on Environmental and Occupational Health. Questionnaire on respiratory symptoms. London, Medical Research Council, 1986.
8. Brille D, Bolt W, Greve LH, Minette A, Sartorelli E. European Coal and Steel Community (ECSC): high authority questionnaire on the study of chronic bronchitis and emphysema. Luxembourg, ECSC, 1962.
9. Minette A. Questionnaire of the European Community for Coal and Steel (ECSC) on respiratory symptoms: 1987 - updating of the 1962 and 1967 questionnaires for studying chronic bronchitis and emphysema. Eur Respir J 1989; 2: 165-177.
10. US Department of Health, Education and Welfare. Proceedings, First National Heart and Lung Institute Epidemiology Workshop. Washington DC, US Government Printing Office, 1971.
11. Ferris BG. Epidemiology Standardization Project. II. Recommended respiratory disease questionnaires for use with adults and children in epidemiological research. Am Rev Respir Dis 1978; 118: 7-57.
12. Lebowitz MD, Knudson RJ, Burrows B. Tucson epidemiologic study of obstructive lung diseases: I. Methodology and prevalence of disease. Am J Epidemiol 1975; 102: 137-152.
13. Lebowitz MD, Burrows B. Comparison of questionnaires: the BMRC and NHLI respiratory questionnaires and a new self-completion questionnaire. Am Rev Respir Dis 1976; 113: 627-635.
14. Burney PJG. Chinn S. Developing a new questionnaire for measuring the prevalence and distribution of asthma. Chest 1987; 91: Suppl. 6, 79s-83s.
15. Burney PGJ, Laitinen LA, Perdrizet S, et al. Validity and repeatability of the IUATLD (1984) Bronchial Symptoms Questionnaire: an international comparison. Eur Respir J 1989; 2: 940-945.
16. Toren K, Brisman J, Järvholm B. Asthma and asthma-like symptoms in adults assessed by questionnaires. A literature review. Chest 1993; 104: 600-608.
17. Burney PGJ, Luczynska C, Chinn S, Jarvis D. The European Community Health Survey. Eur Respir J 1994; 7: 954-960.
18. Asher MI, Keil U, Anderson HR, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995; 8: 483-491.
19. Riboli E, Kaaks R. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997; 26: Suppl. 1, S6-S14.
20. Kauffmann F, Dizier MH. EGEA (Epidemiological study on the Genetics and Environment of Asthma, bronchial hyper-responsiveness and atopy) - design issues. EGEA Co-operative Group. Clin Exp Allergy 1995; 25: Suppl. 2, 19-22.
21. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-completed measure of health status for chronic airflow limitation - the St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321-1327.
22. Giuntini C, Viegi G. Epidemiologic determinants of COPD in some European Countries. Eur Respir Rev 2001; 11: 80.
23. Pistelli F, Viegi G, Carrozzi L, Rönmark E, Lundbäck B, Giuntini G. Usefulness of a compendium of respiratory standard questionnaires for adults (CORSQ). Eur Respir Rev 2001; 11: 80, 98-102.
24. Pistelli F, Viegi G, Carrozzi L, Rönmark E, Lundbäck B, Giuntini G. Appendix 3: Compendium of respiratory standard questionnaires for adults (CORSQ). Eur Respir Rev 2001; 11: 80, 118-143.
25. Peto R, Speizer FE, Cochrane AL, et al. The relevance in adults of airflow obstruction, but not of mucus hypersecretion to mortality from chronic lung disease. Am Rev Respir Dis 1983; 128: 491-500.
26. Thomason MJ, Strachan DP. Which spirometric indices best predict subsequent death from chronic obstructive pulmonary disease. Thorax 2000; 55: 785-788.
27. Weiss ST, Segal MR, Sparrow D, Wager C. Relation of FEV1 and peripheral blood leukocyte count to total mortality. The Normative Aging Study. Am J Epidemiol 1995; 142: 493-498.
28. Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996; 313: 711-715.
29. Schunemann HJ, Dorn J, Grant BJB, Winkelstein W Jr, Trevisan M. Pulmonary function is a long-term predictor of mortality in the general population. Chest 2000; 118: 656-664.
30. Milne JS, Williamson J. Respiratory function tests in older people. Clin Sci 1972; 42: 371-381.
31. Sherman CB, Kern D, Richardson ER, Hubert M, Fogel BS. Cognitive function and spirometric performance in the elderly. Am Rev Respir Dis 1993; 148: 123-126.
32. Enright PL, Kronmal RA, Higgins M, Schenker M, Haponik EF. Spirometric reference values for women and men 65 to 85 years of age. Cardiovascular health study. Am Rev Respir Dis 1993; 147: 125-133.
33. Bellia V, Pistelli R, Catalano F, et al. Quality control of spirometry in the elderly. The SA.R.A. study. Am J Respir Crit Care Med 2000; 161: 1094-1100.
34. Carvalhaes-Neto N, Lorino H, Gallinari C, et al. Cognitive function and assessment of lung function in the elderly. Am J Respir Crit Care Med 1995; 152: 1611-1615.
35. Chyou P-H, White LR, Yano K, et al. Pulmonary function measures as predictors and correlates of cognitive functioning in later life. Am J Epidemiol 1996; 143: 750-756.
36. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: 1202-1218.
37. Sharp DS, Enright PL, Chiu D, Burchfield CM, Rodriguez BL, Curb D. Reference values for pulmonary function tests of Japanese-American men aged 71 to 90 years. Am J Respir Crit Care Med 1996; 153: 805-811.
38. Pistelli R and SA.R.A. study group. Reference equations for spirometric variables in elderly Italian subjects: the SA.R.A. study. Eur Respir J 1999; 14: 292s-293s.
39. Miller MR, Dickinson SA, Hitchings DJ. The accuracy of portable peak flow meters. Thorax 1992; 47: 904-909.
40. Paggiaro PL, Moscato G, Giannini D, et al. The Italian Working Group on the use of peak expiratory flow rate (PEFR) in asthma. Eur Respir Rev 1993; 314, 438-443.
41. Irvin CG, Martin RJ, Chinchilli VM, Kunselman SJ, Cherniack RM and and the Asthma clinical research network (ACRN). Quality control of peak flow meters for multicenter clinical trials. Am J Respir Crit Care Med 1997: 156: 396-402.
42. American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
43. Thiadens HA, De Bock GH, Van Houwelingen, et al. Can peak expiratory flow measurements reliably identify the presence of airway obstruction and bronchodilator response as assessed by FEV1 in primary care patients presenting with a persistent cough? Thorax 1999; 54: 1055-1060.
44. Giannini D, Paggiaro PL, Moscato G, et al. Comparison between peak expiratory flow and forced expiratory volume in one second (FEVI) during bronchoconstriction induced by different stimuli. J Asthma 1997; 34: 105-111.
45. Malo JL, Trudeau C, Ghezzo H, L'Archeveque J, Cartier A. Do subjects investigated for occupational asthma through serial peak expiratory flow measurements falsify their results? J Allergy Clin Immunol 1995; 96: 601-607.
46. Verschelden P, Cartier A, L'Archeveque J, Trudeau C, Malo JL. Compliance with and accuracy of daily self-assessment of peak expiratory flows (PEF) in asthmatic subjects over a three month period. Eur Respir J 1996; 9: 880-885.
47. Venables KM, Burge PS, Davison AG, Newman Taylor AJ. Peak flow rate records in surveys: reproducibility of observers' reports. Thorax 1984; 39: 828-832.
48. Di Pede F, Paggiaro PL, Viegi G, et al. "PEAK": sistema computerizzato di archiviazione ed analisi delle misure del picco di flusso espiratorio. Limiti di normale variabilità. Giorn It Allergol Immunol Clin 1993; 3: 303-310.
49. Reddel KH, Salome CM, Peat JK, Woolcock AJ. Which index of peak expiratory flow is most useful in the management of stable asthma?. Am J Respir Crit Care Med 1995; 151: 1320-1325.
50. Siersted HC, Hansen HS, Hansen NCG, Hyldebrant N, Mostgaard G, Oxhoj H. Evaluation of peak expiratory flow variability in an adolescent population sample. Am J Respir Crit Care Med 1994; 149: 598-603.
51. Higgins BG, Britton JR, Chinn S, Cooper S, Burney PGJ, Tattersfield AE. Comparison of bronchial reactivity and peak expiratory flow variability measurements for epidemiological studies. Am Rev Respir Dis 1992; 145: 588-593.
52. Goldstien MF, Veza BA, Dunsky EH, Dvorin DJ, Belecanech GA, Haralabatos IC. Comparison of peak diurnal flow variation, postbronchodilator FEV1 responses, and methacholine inhalation challenges in the evaluation of suspected asthma. Chest 2001; 119: 1001-1010.
53. Brand PLP, Duiverman EJ, Waalkens HJ, van Essen-Zandvliet EEM, Kerrebijn KF and and the Dutch CNSLD Study group. Peak flow variation in childhood asthma: correlation with symptoms, airway obstruction, and hyper-responsiveness during long term treatment with inhaled corticosteroids. Thorax 1999; 54: 103-107.
54. Douma WR, Kerstjens HAM, Roos CM, Koeter GH, Postma DS, and the Dutch Chronic non-specific Lung Disease study group. Changes in peak expiratory flow indices as a proxy for changes in bronchial hyperresponsiveness. Eur Respir J 2000; 16: 220-225.
55. Chan-Yeung M, Chang JH, Manfreda J, Ferguson A, Becker A. Changes in peak flow, symptoms score, and the use of medications during acute exacerbations of asthma. Am J Respir Crit Care Med 1996; 154: 889-893.
56. Cook NR, Evans DA, Scherr PA, et al. Peak expiratory flow rate in an elderly population. Am J Epidemiol 1989; 130: 66-78.
57. Cook NR, Evans DA, Scherr PA, Speizer FE, Taylor JO, Hennekens CH. Peak expiratory flow rate and 5-year mortality in an elderly population. Am J Epidemiol 1991; 133: 784-794.
58. Boezen HM, Rijcken B, Schouten JP, Postma DS. Breathlessness in elderly individuals is related to low lung function and reversibility of airway obstruction. Eur Respir J 1998; 12: 805-810.
59. Bellia V, Cuttitta G, Cibella F, et al. Effect of aging on peak expiratory flow variability and nocturnal exacerbations in bronchial asthma. Eur Respir J 1997; 10: 1803-1808.
60. Brunekreef B, Dockery DW, Krzyzanowski M. Epidemiological studies on short-term effects of low levels of major ambient air pollution components. Envir Health Perspect 1995; 103: Suppl. 2, 3-13.
61. Van der Zee SC, Hoek G, Boezen MH, Schouten JP, van Wijnen JH, Brunekreef B. Acute effects of air pollution on respiratory health of 50-70-yr-old adults. Eur Respir J 2000; 15: 700-709.
62. Viegi G, Paoletti P, Prediletto R, et al. Prevalence of respiratory symptoms in an unpolluted area of Northern Italy. Eur Respir J 1988; 1: 311-318.
63. Lundback B, Sjernberg N, Nystrom L, Lundback K, Lindstrom M, Rosenhall J. An interview study to estimate prevalence of asthma and chronic bronchitis. The Obstructive Lung Disease in Northern Sweden Study. Eur J Epidemiol 1993; 9: 123-133.
64. Bakke P, Gulsvik A, Lilleng P, Overa O, Hanoa R, Eide GE. Postal surveys on airborne occupational exposure and respiratory disorders in Norway: causes and consequences of non-response. J Epidemiol Community Health 1990; 44: 316-320.
65. P Tønnesen P, Paoletti P, Gustavsson G, et al. Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Eur Respir J 1999; 13: 238-246.
66. Roemer W, Hoek G, Brunekreef B. Pollution effects on asthmatic children in Europe, the PEACE study. Clin Exp Allergy 2000; 30: 1067-1075.
67. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991; 85: Suppl. B, 25-31.